Prenatal Genetic Screening and Embryonic Morphological Assessment for Early Detection of Developmental Abnormalities
- Aug 17
- 2 min read
Original Research | 2026 | Volume 2 | Issue 1 | Page 17-37
Dr Sonali's Supreme Scan, Department of Radiology, Mullanpur , District Ludhiana, Punjab
Abstract
Background: Developmental abnormalities are an important cause of fetal and neonatal morbidity, mortality, and long-term disability. Advances in prenatal genetic screening and high-resolution fetal imaging have improved opportunities for identifying chromosomal, genetic, and structural abnormalities during early pregnancy. Integrating genetic information with detailed embryonic and fetal morphological assessment may provide a more comprehensive approach to early risk detection and clinical decision-making.
Objective: This study aims to evaluate the combined utility of prenatal genetic screening and embryonic morphological assessment for the early detection of developmental abnormalities and to examine their complementary roles in prenatal diagnosis.
Methods: Pregnant women undergoing routine first- and second-trimester prenatal evaluation were assessed using maternal clinical characteristics, biochemical screening, cell-free fetal DNA-based screening where indicated, and ultrasonographic morphological examination. Parameters including crown–rump length, nuchal translucency, nasal bone development, fetal anatomy, cardiac structures, limb formation, craniofacial morphology, and other developmental markers were evaluated. Pregnancies identified as high risk were considered for confirmatory diagnostic procedures and genetic testing according to clinical indications.
Results: The integrated assessment demonstrated improved identification of pregnancies at increased risk for chromosomal abnormalities, congenital malformations, and developmental disorders compared with reliance on a single screening modality. Abnormal genetic screening results were frequently associated with specific sonographic markers, while morphological assessment also identified structural abnormalities in pregnancies without evident screening abnormalities. The complementary use of both approaches facilitated earlier risk stratification and more targeted diagnostic evaluation.
Conclusion: Combining prenatal genetic screening with systematic embryonic and fetal morphological assessment provides a comprehensive framework for the early detection of developmental abnormalities. Such an integrated approach may improve prenatal counseling, guide confirmatory testing, support timely clinical decision-making, and contribute to personalized prenatal care.
Keywords: Prenatal genetic screening; fetal morphology; embryonic development; congenital abnormalities; chromosomal abnormalities; cell-free fetal DNA; prenatal diagnosis; ultrasonography.